1ZUA | X:15-294 | CRYSTAL STRUCTURE OF AKR1B10 COMPLEXED WITH NADP+ AND TOLRESTAT |
1MRQ | A:18-301 | CRYSTAL STRUCTURE OF HUMAN 20ALPHA-HSD IN TERNARY COMPLEX WITH NADP AND 20ALPHA-HYDROXY-PROGESTERONE |
3NTY | A:18-301 | CRYSTAL STRUCTURE OF AKR1C1 IN COMPLEX WITH NADP AND 5-PHENYL,3-CHLOROSALICYLIC ACID |
1XJB | B:18-301; B:18-301 | CRYSTAL STRUCTURE OF HUMAN TYPE 3 3ALPHA-HYDROXYSTEROID DEHYDROGENASE IN COMPLEX WITH NADP(H), CITRATE AND ACETATE MOLECULES |
1RY0 | B:18-301; B:18-301 | STRUCTURE OF PROSTAGLANDIN F SYNTHASE WITH PROSTAGLANDIN D2 |
1RY8 | B:18-301; B:18-301 | PROSTAGLANDIN F SYNTHASE COMPLEXED WITH NADPH AND RUTIN |
1S1P | A:18-301 | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
1S1R | A:18-301 | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE (AKR1C3) IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
1S2A | A:18-301 | CRYSTAL STRUCTURES OF PROSTAGLANDIN D2 11-KETOREDUCTASE IN COMPLEX WITH THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FLUFENAMIC ACID AND INDOMETHACIN |
1XF0 | A:18-301 | CRYSTAL STRUCTURE OF HUMAN 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 (AKR1C3) COMPLEXED WITH DELTA4-ANDROSTENE-3,17-DIONE AND NADP |
1ZQ5 | A:18-301 | CRYSTAL STRUCTURE OF HUMAN ANDROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 5 IN COMPLEXED WITH A POTENT INHIBITOR EM1404 |
1PWL | A:14-293 | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND MINALRESTAT |
1PWM | A:14-293 | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND FIDARESTAT |
1T40 | A:14-293 | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND IDD552 AT PH 5 |
1T41 | A:14-293 | CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND IDD552 |
1US0 | A:14-293 | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR IDD594 AT 0.66 ANGSTROM |
1X96 | A:14-293 | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE WITH CITRATES BOUND IN THE ACTIVE SITE |
1X97 | A:14-293 | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2R4S (STEREOISOMER OF FIDARESTAT, 2S4S) |
1X98 | A:14-293 | CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2S4R (STEREOISOMER OF FIDARESTAT, 2S4S) |
1XGD | A:14-293 | APO R268A HUMAN ALDOSE REDUCTASE |
1Z3N | A:14-293 | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR LIDORESTAT AT 1.04 ANGSTROM |
1Z8A | A:14-293 | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL SULFONYL-PYRIDAZINONE INHIBITOR |
2NVC | A:14-293 | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL NAPHTHO[1,2-D]ISOTHIAZOLE ACETIC ACID DERIVATIVE (3) |
2NVD | A:14-293 | HUMAN ALDOSE REDUCTASE COMPLEXED WITH NOVEL NAPHTHO[1,2-D]ISOTHIAZOLE ACETIC ACID DERIVATIVE (2) |
2PD5 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT V47I COMPLEXED WITH ZOPOLRESTAT |
2PD9 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT V47I COMPLEXED WITH FIDARESTAT. |
2PDB | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT F121P COMPLEXED WITH ZOPOLRESTAT. |
2PDC | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT F121P COMPLEXED WITH IDD393. |
2PDF | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT L300P COMPLEXED WITH ZOPOLRESTAT. |
2PDH | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT L300P COMPLEXED WITH URACIL-TYPE INHIBITOR AT 1.45 A. |
2PDI | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT L300A COMPLEXED WITH ZOPOLRESTAT AT 1.55 A. |
2PDN | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT S302R COMPLEXED WITH URACIL-TYPE INHIBITOR. |
2PDP | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT S302R COMPLEXED WITH IDD 393. |
2PDQ | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH URACIL-TYPE INHIBITOR. |
2PDU | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH IDD393. |
2PDW | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT C303D COMPLEXED WITH FIDARESTAT. |
2PDX | A:14-293 | HUMAN ALDOSE REDUCTASE DOUBLE MUTANT S302R-C303D COMPLEXED WITH ZOPOLRESTAT. |
2PDY | A:14-293 | HUMAN ALDOSE REDUCTASE DOUBLE MUTANT S302R-C303D COMPLEXED WITH FIDARESTAT. |
2PEV | A:14-293 | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION EXCEEDS CONCENTRATION OF IDD594. |
2PF8 | A:14-293 | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION IS EQUAL TO CONCENTRATION OF IDD594. |
2PFH | A:14-293 | COMPLEX OF ALDOSE REDUCTASE WITH NADP+ AND SIMALTANEOUSLY BOUND COMPETETIVE INHIBITORS FIDARESTAT AND IDD594. CONCENTRATION OF FIDARESTAT IN SOAKING SOLUTION IS LESS THAN CONCENTRATION OF IDD594. |
2PZN | A:14-293 | THE CRYSTALLOGRAPHIC STRUCTURE OF ALDOSE REDUCTASE IDD393 COMPLEX CONFIRMS LEU300 AS A SPECIFICITY DETERMINANT |
2QXW | A:14-293 | PERDEUTERATED ALR2 IN COMPLEX WITH IDD594 |
2R24 | A:14-293 | HUMAN ALDOSE REDUCTASE STRUCTURE |
3LBO | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113C COMPLEXED WITH IDD594 |
3LD5 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH IDD594 |
3LEN | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH ZOPOLRESTAT |
3LEP | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113C IN COMPLEX WITH IDD388 |
3LQG | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD388 |
3LQL | A:15-294 | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD 594 |
3LZ3 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH IDD388 |
3LZ5 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD594 |
3M0I | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V IN COMPLEX WITH ZOPOLRESTAT |
3M4H | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD388 |
3M64 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V COMPLEXED WITH IDD393 |
3MB9 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH ZOPOLRESTAT |
3MC5 | A:14-293 | HUMAN ALDOSE REDUCTASE MUTANT T113V IN COMPLEX WITH IDD393 CRYSTALLIZED IN SPACEGROUP P1 |
3Q65 | B:14-293; B:14-293 | HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ IN SPACE GROUP P212121 |
3Q67 | B:14-293; B:14-293 | HUMAN ALDOSE REDUCTASE C298S MUTANT IN COMPLEX WITH NADP+ IN SPACE GROUP P212121 |
1ZSX | A:37-332 | CRYSTAL STRUCTURE OF HUMAN POTASSIUM CHANNEL KV BETA-SUBUNIT (KCNAB2) |